HOOKIPA Pharma
HOOK
HOOK was delisted on the 7th of August, 2025.
72 hedge funds and large institutions have $32.7M invested in HOOKIPA Pharma in 2021 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 23 increasing their positions, 21 reducing their positions, and 13 closing their positions.
10% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 21
0.51% more ownership
Funds ownership: 4.86% → 5.37% (+0.51%)
0% more funds holding
Funds holding: 72 → 72 (0)
0% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 13
28% less call options, than puts
Call options by funds: $64K | Put options by funds: $89K
56% less capital invested
Capital invested by funds: $74.2M → $32.7M (-$41.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$2.7M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$2.17M |
| 3 |
Renaissance Technologies
New York
|
+$1.58M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$687K |
| 5 |
Two Sigma Advisers
New York
|
+$675K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WP
Woodline Partners
San Francisco,
California
|
-$3.97M |
| 2 |
UBS AM
Chicago,
Illinois
|
-$1.89M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$560K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$344K |
| 5 |
Los Angeles Capital Management
Los Angeles,
California
|
-$298K |
HOOK Hedge Fund Activity: Q4 2021 in Review
72 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in HOOKIPA Pharma (HOOK) for Q4 2021, worth a combined $32.7M — down 56% from $74.2M a quarter earlier.
Fund positioning in HOOK was balanced in Q4 2021: 13 funds opened new positions, 13 closed out, 23 added to existing stakes and 21 trimmed.
The largest buyer was Bank of America, adding an estimated $2.7M. The largest seller was Woodline Partners, exiting entirely with an estimated $3.97M sold.
- 72 institutional investors held HOOKIPA Pharma (HOOK) as of Q4 2021, unchanged from Q3 2021.
- Funds reported $32.7M of HOOKIPA Pharma stock for Q4 2021, down 56% quarter-over-quarter.
- 13 funds opened new HOOKIPA Pharma positions in Q4 2021 and 13 closed out, a net change of 0 holders.
- The largest HOOKIPA Pharma buyer in Q4 2021 was Bank of America, an estimated $2.7M added.
- The largest HOOKIPA Pharma seller in Q4 2021 was Woodline Partners, an estimated $3.97M sold.
Based on aggregated 13F filings for Q4 2021.